Literature DB >> 21490274

Community health care: therapeutic opportunities in the human microbiome.

Justin L Sonnenburg1, Michael A Fischbach.   

Abstract

We are never alone. Humans coexist with diverse microbial species that live within and upon us--our so-called microbiota. It is now clear that this microbial community is essentially another organ that plays a fundamental role in human physiology and disease. Basic and translational research efforts have begun to focus on deciphering mechanisms of microbiome function--and learning how to manipulate it to benefit human health. In this Perspective, we discuss therapeutic opportunities in the human microbiome.

Entities:  

Mesh:

Year:  2011        PMID: 21490274      PMCID: PMC3287364          DOI: 10.1126/scitranslmed.3001626

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  36 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.

Authors:  Bret D Wallace; Hongwei Wang; Kimberly T Lane; John E Scott; Jillian Orans; Ja Seol Koo; Madhukumar Venkatesh; Christian Jobin; Li-An Yeh; Sridhar Mani; Matthew R Redinbo
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

3.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

4.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

6.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

Review 7.  Probiotics for treating persistent diarrhoea in children.

Authors:  Guillermo Bernaola Aponte; Carlos Alfonso Bada Mancilla; Nilton Yhuri Carreazo Pariasca; Raúl Alberto Rojas Galarza
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

8.  Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

Authors:  Sinéad C Corr; Yin Li; Christian U Riedel; Paul W O'Toole; Colin Hill; Cormac G M Gahan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

Review 9.  Genetically modified Streptococcus mutans for the prevention of dental caries.

Authors:  Jeffrey D Hillman
Journal:  Antonie Van Leeuwenhoek       Date:  2002-08       Impact factor: 2.271

Review 10.  An ecological and evolutionary perspective on human-microbe mutualism and disease.

Authors:  Les Dethlefsen; Margaret McFall-Ngai; David A Relman
Journal:  Nature       Date:  2007-10-18       Impact factor: 69.504

View more
  36 in total

1.  Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates.

Authors:  Erica D Sonnenburg; Justin L Sonnenburg
Journal:  Cell Metab       Date:  2014-08-21       Impact factor: 27.287

2.  Community health care: therapeutic opportunities in the human microbiome.

Authors:  Justin L Sonnenburg; Michael A Fischbach
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

3.  Blood Microbiome in CKD: Should We Care?

Authors:  Robert D Mair; Tammy L Sirich
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-08       Impact factor: 8.237

4.  The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota.

Authors:  Laura M Cox; Ilseung Cho; Scott A Young; W H Kerr Anderson; Bartholomew J Waters; Shao-Ching Hung; Zhan Gao; Douglas Mahana; Monika Bihan; Alexander V Alekseyenko; Barbara A Methé; Martin J Blaser
Journal:  FASEB J       Date:  2012-11-14       Impact factor: 5.191

5.  Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation.

Authors:  Peera Hemarajata; James Versalovic
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 6.  A brief history of synthetic biology.

Authors:  D Ewen Cameron; Caleb J Bashor; James J Collins
Journal:  Nat Rev Microbiol       Date:  2014-04-01       Impact factor: 60.633

Review 7.  Microbiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection.

Authors:  Elizabeth S McKenney; Melissa M Kendall
Journal:  Pathog Dis       Date:  2016-05-31       Impact factor: 3.166

Review 8.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

Review 9.  The human microbiome is a source of therapeutic drug targets.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Curr Opin Chem Biol       Date:  2013-05-13       Impact factor: 8.822

10.  Shifts in the Fecal Microbiota Associated with Adenomatous Polyps.

Authors:  Vanessa L Hale; Jun Chen; Stephen Johnson; Sean C Harrington; Tracy C Yab; Thomas C Smyrk; Heidi Nelson; Lisa A Boardman; Brooke R Druliner; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Peter Lance; David A Ahlquist; Nicholas Chia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-26       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.